TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ACHV

Achieve Life Sciences Inc

Healthcare · Biotechnology

7.80$ +0.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ACHV
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– +9.4% -23.0% +50.0% +0.0% -9.9% +0.4% -2.0% -5.6% -3.4% +0.4% -0.4%
– -39.7% -29.2% -78.9% +145.4% +40.6% +7.1% +70.1% +49.5% +5.2% +54.8% +64.5%
– – +126.9% +358.6% -81.0% +40.6% +7.1% +73.3% +46.8% – – –
– -39.3% -252.6% – – -129.4% – – -93.6% -1,084.8% – -276.9%
– +352.4% -87.6% +0.0% +0.0% +15.2% -67.9% +0.0% -100.0% – -100.0% –
– -138.7% – +19.2% -140.5% – -100.3% +0.0% – – +102,661.9% –
– – – – – – – – – – – –
– -99.9% -100.0% – – -66.3% +554.8% – – +63,729.8% -100.0% –
– +25.8% -95.9% +1,194.7% +668.7% +0.0% +0.0% +0.0% -100.1% -100.0% – –
– -30.3% -100.0% – +887.4% -12.3% +88.6% +12.0% -47.2% -20.9% +217.6% +6.2%
– -51.8% -397.5% – -27.6% +78.3% +168.4% -62.6% -354.6% – – –
– – – – – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?